BRAF Alteration in Central and Peripheral Nervous System Tumors

Medicine and Dentistry

• Neoplasm 100%
• Peripheral Nervous System 100%
• Central Nervous System 100%
• Nervous System Tumor 100%
• Diagnosis 66%
• Central Nervous System Tumor 66%
• Prevalence 33%
• Targeted Therapy 33%
• Mitogen-Activated Protein Kinase 33%
• Missense Mutation 33%
• Neuroepithelioma 33%
• Central Nervous System Metastasis 33%
• Proto Oncogene 33%
• Virus Oncogene 33%
• Connective Tissue Cancer 33%

Keyphrases

• Central Nervous System Tumors 100%
• Peripheral Nervous System Tumours 100%
• BRAF Alteration 100%
• Mitogen-activated Protein Kinase 33%
• Tumor 33%
• Prognostic Implications 33%
• Therapeutic Implications 33%
• Targeted Therapy 33%
• Oncogene 33%
• Missense mutation 33%
• CNS Metastases 33%
• CNS Tumors 33%
• Diagnostic Aspects 33%
• Multinodular 33%
• Novel Entities 33%
• Polymorphous Low-grade Neuroepithelial Tumor of the Young (PLNTY) 33%
• Vacuolating Neuronal Tumor 33%
• V-raf murine Sarcoma Viral Oncogene Homolog B1 33%
• DLGNT 33%